Table 2.
Plant name | Plant part used | Isolated compound/ extract used |
Chemical class | Assay type | Mechanism of action/conclusion | References |
---|---|---|---|---|---|---|
Clerodendron phlomidis Linn. | Leaves | Aqueous extract | – | In vivo | Concentration of 100 mg/kg potently reduced blood eosinophil count, mast cell degranulation and histamine release in sensitized mice. | (Vadnere et al., 2007) |
Ex vivo | Potent antagonizing effect of histamine-induced goat tracheal contraction at doses of 4 mg/ml and 10 mg/ml. | (Vadnere et al., 2007) | ||||
Clerodendrum serratum (Linn.) Moon | Root and stem | Aqueous extract | – | In vivo | Root extract resulted in no significant increase of leucocyte and eosinophil count at 260 mg/kg in milk-induced leucocytosis mice and prolonged PCD at 156 mg/kg in egg albumin-sensitized guinea pigs. | (Bhangare et al., 2012) |
Clerodendron trichotomum Thunb. | Leaves | Acteoside (22) | Phenylpropanoid glycoside | In vivo | At dose of 50 mg/kg significantly inhibited eosinophil infiltration, decreased histamine content and phospholipase A2 activity in BALF while at 25 mg/kg, recruitment of leukocytes was suppressed and inhibited sRaw in both IAR and LAR in sensitized guinea pigs model. | (Lee et al., 2011b) |
Clinopodium gracile (Benth.) Matsum var. multicaule | Whole plant | Aqueous extract | – | In vivo | Compound 48/80-induced mice were observed with concentration-dependently reduced anaphylactic death with intraperitoneally administration at concentrations ranging from 1-100 mg/kg and the same reduction manner was seen in IgE-mediated PCA reaction. | (Park et al., 2010) |
In vitro | Dose-dependent inhibition of histamine release inhibition from RPMC and HMC-1 cells respectively across 1-100 µg/ml. Allergic inflammation reduced with the attenuation of intracellular calcium, NF-κB, gene expression and secretion of TNF-α and IL-6 stimulated by PMACI in HMC-1 cells. | (Park et al., 2010) | ||||
Dracocephalum argunense Fisch. | Whole plant | Aqueous extract | – | In vivo | Significant inhibition of systemic anaphylaxis with intraperitoneal administration of aqueous extract in mice at concentration range of 0.01–1 g/kg. Serum histamine and PCA inhibition were reduced in a dose-dependent manner. | (Kim et al., 2006; Kim and Shin, 2006) |
In vitro | Decreased intracellular calcium and histamine release from RPMC in dose dependent manner with concentrations of 0.001–1 mg/ml. TNF-α and IL-6 gene expression in HMC-1 cells were inhibited across doses ranging from 0.01–1 mg/ml with the involvement of NF-κB attenuation. |
(Kim et al., 2006; Kim and Shin, 2006) | ||||
Elsholtzia ciliate (Thunb.) Hyland | Whole plant | Aqueous extract | – | In vivo | Serum histamine, systemic anaphylaxis and PCA reaction observed with dose-related inhibition at concentrations of 10–1,000 mg/kg. | (Kim et al., 2011) |
In vitro | Significantly inhibited histamine release at 10 and 100 µg/ml of aqueous extract and recorded with reduction of PMACI-stimulated intracellular calcium at 100 µg/ml of aqueous extract pretreatment in HMC-1 cells. Gene expression and production of IL-6, IL-1β and TNF-α were suppressed through inhibition of NF-κB activation and p38 MAPK pathway with concentrations ranging from 1-100 µg/ml. | (Kim et al., 2011) | ||||
Isodon japonicas Hara | Whole plant | Aqueous extract | – | In vivo | Challenged-mice protected from systemic allergic death and PCA with intraperitoneal administration of extract at concentration of 0.1 g/kg. | (Kim et al., 2004; Shin et al., 2004) |
In vitro | Dose-dependently decreased histamine release from RPMC stimulated by compound 48/80 or anti-DNP IgE at doses ranging from 0.001-1 mg/ml and reduced gene expression and production of TNF-α and IL-6 in PMACI-stimulated HMC-1 cells. |
(Kim et al., 2004; Shin et al., 2004) | ||||
Lagochilus leiacanthus Fisch. & C.A.Mey. | Whole plant | 5,2’,6’-trihydroxy-7,8-dimethoxyflavanone (23), 5,2’,6’-trihydroxy-6,7,8-trimethoxyflavanone (24), 5,2’-dihydroxy-6,7,8,6’-tetramethoxyflavanone (25), Oroxylin-A (14), Hispidulin (26), 5,2’,6’-trihydroxy- 6,7,8-trimethoxyflavone (27), 5,7,2’-trihydroxy-8,6’- dimethoxyflavone (28), 5,6,2’-trihydroxy-7,8,6’-trimethoxyflavone (29) |
Flavonoid | In vitro | Significantly inhibited the release of β-hexosaminidase from RBL-2H3 cells with IC50 values ranging from 13.5-48.9 µM. | (Furukawa et al., 2011) |
Lycopus lucidus Turcz. | Aerial part | Rosmarinic acid (1), clinopodic acid C (17), lycopic acid A (19), clinopodic acid E (18), lycopic acid B (20), scizotenuin A (21) |
Phenylpropanoid | In vitro | Acted as hyaluronidase inhibitor with IC50 of 309, 80.1, 134, 82.8, 141 and 241 µM respectively. | (Murata et al., 2010) |
Whole plant | Aqueous extract | – | In vivo | Systemic anaphylactic death and PCA reaction reduced dose-dependently across concentrations of 0.005–0.1 g/kg in sensitized mice. | (Shin et al., 2005) | |
In vitro | Histamine release potently reduced in compound 48/80 or anti-DNP IgE-stimulated RPMC corresponded to decreased intracellular calcium at dose range of 0.01–1 mg/ml. Attenuation of NF-κB caused a reduction in downstream cytokines, such as TNF-α and IL-6 expression. | (Shin et al., 2005) | ||||
Marrubium vulgare Linn. | Aerial part | Marrubiin (30) | Furane labdane diterpene | In vitro | Maximal inhibition (67.6 ± 4%) of OVA-induced allergic oedema was achieved at dose of 100 mg/kg in actively sensitized mice. | (Stulzer et al., 2006) |
Melissa officinalis Linn. | Leaves | Rosmarinic acid (1) | Phenylpropanoid | In vitro | Exhibited potent suppressive effect on hyaluronidase with 1.0 ± 0.3% of enzyme activity. | (Ippoushi et al., 2000) |
Mentha arvensis Linn. | Leaves, roots and stem | Ethanolic and aqueous extract | – | In vivo | 100 µg/ml ethanolic leaf and root extract showed potent histamine inhibition at 57% and 53% respectively in mice. | (Malik et al., 2003) |
Whole plant | Aqueous extract | – | In vivo | Anal administration of 0.05 g/kg extract protected mice from anaphylactic death. PCA reaction reduced dose-dependently with intraperitoneal, oral and intravenous administration of extract. | (Shin, 2003) | |
In vitro | Significant reduction in histamine release at 0.1 and 1 mg/ml of extract in compound 48/80-induced and anti-DNP IgE-mediated model in RPMC. TNF-α production reduced significantly at concentration of 0.1 mg/ml in RPMC. | (Shin, 2003) | ||||
– | Essential oil | – | In vivo | Dose-dependently reduced histamine-induced bronchoconstriction in guinea pigs at 200 and 400 µl/kg and significantly reduced eosinophil count, serum IgE level and BALF eosinophils in OVA-sensitized mice at 200 µl/kg. | (Sharma et al., 2018) | |
Mentha haplocalyx Briq. | Aerial part | Ethanolic extract | – | In vivo | Observed with inhibition of eosinophil infiltration, TH2 cytokines (IL-4, IL-5) expression and production in OVA-sensitized mice. | (Lee et al., 2011a) |
Mentha piperita Linn. | Leaves | 50% ethanolic eluate | – | In vivo | Decreased nasal responses in antigen-induced rats at 300 and 1,000 mg/kg. | (Inoue et al., 2001) |
In vitro | Recorded with potent inhibition of histamine release from RPMC with IC50 of 2.55 (1.42–3.94) µg/ml. | (Inoue et al., 2001) | ||||
Leaves | Luteolin-7-O-rutinoside (31) | Flavonoid glycoside | In vivo | Reduced frequency of sneezing at 100 and 300 mg/kg while nasal rubbing was seen in antigen-induced rats at 100 mg/kg or more. | (Inoue et al., 2002) | |
In vitro | Suppression of histamine release from compound 48/80-induced RPMC with IC50 value of 21.9 µM. | (Inoue et al., 2002) | ||||
Mentha piperita var. citrata (Ehrh.) Briq. | Leaves | 5,6,4’-trihydroxy-7,8-dimethoxyflavone (32), 5,6,4’-trihydroxy-7,8,3’- trimethoxyflavone (33), 5,6-dihydroxy-7,3’,4’- trimethoxyflavone (34), 5,6-dihydroxy-7,8, 3’, 4’- tetramethoxyflavone (35), 5,6-dihydroxy-7,8, 4’-trimethoxyflavone (36) |
Flavonoid | In vitro | Significantly reduction of β-hexosaminidase release from RBL-2H3 at IC50 range of 2.4–6.7 µM. | (Sato and Tamura, 2015) |
Mentha spicata L. var. crispa Benth. | Leaves | 5,6-dihydroxy-7,8,3’,4’-tetramethoxyflavone (35), 5,6,4’-trihydroxy-7,8,3’-trimethoxyflavone (33), (3R)-1-octan-3-yl β-D-glucopyranoside (37) |
Flavonoid and aliphatic glycoside |
In vivo | Demonstrated β-hexosaminidase release suppression from rat basophils at 56, 6.4 and 560 µM respectively. | (Yamamura et al., 1998) |
Minthostachys verticillata (Griseb.) Epling | Leaves and stems | Essential oil | – | In vitro | β-hexosaminidase release from human basophils was diminished by 32.15% to 39.72% as comparable to dexamethasone and theophylline. | (Cariddi et al., 2007) |
Leaves and stems | Limonene (38), Pulegone (39), Menthone (40) |
Monoterpene | In vivo | (38) maximally suppressed PCA reaction in challenged-mice at 250 mg/kg. | (Cariddi et al., 2011) | |
In vitro | The combination of the three constituents in essential oil significantly suppressed the production of IL-13 from human PBMC. Potent inhibitory effect on β-hexosaminidase release from human basophils was observed with a concentration range of 10–40 µg/ml. | (Cariddi et al., 2011) | ||||
Mosla chinensis Max. | Whole plant | Aqueous extract | – | In vivo | Observed with concentration dependent suppression of systemic anaphylaxis and PCA reaction with doses of ranging from 10–1,000 mg/kg in sensitized mice. | (Kim et al., 2012) |
In vitro | Decreased intracellular calcium caused a dose-dependent reduction of histamine release from RPMC and reduced NF-κB activation resulted in decreased downstream TNF-α, IL-6, IL-8 expression in PMACI-stimulated HMC-1 cells. | (Kim et al., 2012) | ||||
Mosla dianthera Maxim. | Whole plant | Aqueous extract | – | In vivo | Challenged-mice recorded with zero mortality due to systemic shock with pretreatment of 1,000 mg/kg and reduced PCA reaction in a dose-dependent manner across the range of 1–1,000 mg/kg. | (Lee et al., 2006) |
In vitro | Attenuation of histamine release from RPMC at doses ranging from 0.001–1 mg/ml and decreased intracellular calcium, NF-κB activation, gene expression and secretion of TNF-α, IL-6, IL-8 in PMACI-stimulated HMC-1 cells. | (Lee et al., 2006) | ||||
Nepeta bracteata Benth. |
Whole plant | Crude aqueous extract | – | In vivo | Medium dose (not specified dose) exhibited the most potent reduction in the number of TH17 cells, increased number of Treg cells in OVA-sensitized mice and decreased eosinophil infiltration in BALF. | (Wang et al., 2016) |
Ocimum basilicum Linn. | Leaves | Acetone and hydro-methanol extract | – | In vitro | Achieved histamine release suppressive effect of 35.35% and 50.76% respectively at 100 µg/ml. | (Kaur et al., 2018) |
Ocimum gratissimum Linn. | Leaves | Methanolic extract | – | In vivo | Significantly suppressed number of eosinophils, decreased IL-4 level, reduced level of eosinophil peroxidase in BALF and lungs and decreased airway mucus hypersecretion at 100 mg/kg. | (Costa et al., 2012) |
Ocimum sanctum Linn. | Leaves and seeds | Dried and fresh leaves ethanolic extract, volatile oil from fresh leaves and fixed oil from seeds | – | In vivo | Guinea pigs were protected from both histamine-induced and acetylcholine-induced preconvulsive dyspnoea with pretreatment of fresh leaves ethanolic extract, volatile oil and fixed oil. | (Singh and Agrawal, 1991) |
Leaves | Ethanolic extract | – | In vivo | Exhibited significant mast cell stabilizing potential, inhibition of IgE and delayed onset of histamine-induced bronchospasm with 64.25 ± 9.51%, 25.80 ± 4.85 ng/ml and 440 s respectively. | (Sridevi et al., 2009) | |
Leaves | Ethanolic extract and isolated flavonoidal fraction | – | In vivo | Sensitized rats showed with significant mast cell stabilization of 67.24 ± 2.94% with extract administration and 60.48 ± 2.72% with fraction administration. | (Choudhary, 2010) | |
Perilla frutescens Britton | Whole plant | Aqueous extract | – | In vivo | Exhibited dose-dependent inhibition of compound 48/80-induced plasma histamine release at concentration range of 0.01–1 g/kg in sensitized rats. Marked suppression of PCA reaction at doses of 0.1 and 1 g/kg. | (Shin et al., 2000) |
In vitro | At concentration range of 0.001–1 mg/ml, histamine release and TNF-α production were decreased dose-dependently in stimulated RPMC. cAMP level in RPMC significantly increased at 1 mg/ml. | (Shin et al., 2000) | ||||
Whole plant | Rosmarinic acid (1), Apigenin 7-O-[β-glucuronosyl(2→1) β-glucuronide] (2) |
Flavonoid and flavonoid glycoside | In vivo | (1) and (2) suppressed PCA reaction in sensitized mice with percentage inhibition of 41% and 32% respectively. | (Makino et al., 2001) | |
Leaves | Luteolin (3) | Flavonoid | In vivo | Sensitized mice showed with decreased oxazolone-induced ear odema with oral administration of 1 mg of (3). Dose-dependent inhibition of TNF-α production occurred at dose range of 1–1,000 µg. | (Ueda et al., 2002) | |
Leaves | Rosmarinic acid (1) | Phenylpropanoid | In vivo | Equivalent PCA reaction suppression was achieved by 19 mg/kg of (1) as compared to 150 mg/kg of tranilast, the positive control. | (Makino et al., 2003) | |
Leaves | Rosmarinic acid (1) | Phenylpropanoid | In vivo | Oral administration of (1) by Der f-sensitized mice caused reduction in allergen-specific immunoglobulin, eosinophil infiltration, eosinophil counts in BALF, eotaxin, IL-4 and IL-5 expression at concentration of 1.5 mg/day. | (Sanbongi et al., 2004) | |
Leaves | Ethanol extract | – | In vivo | TH2 cytokines (IL-5 and IL-13), serum IgE level, eosinophil infiltration, histamine and eotaxin in BALF were suppressed in OVA-sensitized BALB/c mice. | (Chen et al., 2015) | |
Leaves | Luteolin (3) | Flavonoid | In vivo | Compound 48/80- or serotonin-induced scratching behaviour and vascular permeability were reduced dose-dependently at 5, 10 and 20 mg/kg in sensitized mice. | (Jeon et al., 2014) | |
In vitro | Dose-dependent reduction of compound 48/80-induced histamine release from RPMC marked at 5, 10 and 20 µM. Diminished production of TNF-α (31.9%-76.8%) and IL-1β (27.3%-81.2%) in PMACI-stimulated HMC-1 cells at a range of 5–20 µM of (8). | (Jeon et al., 2014) | ||||
Leaves | Aqueous fraction | – | In vivo | DNFB-sensitized mice experienced 35% reduction of ear swelling symptom at dose of 100 µg/ml. | (Heo et al., 2011) | |
In vitro | At 100 µg/ml, eosinophil counts reduced by 73.7% accompanied with decreased expression of MMP-9 and IL-31 in mice ear tissues. T-bet protein expression was augmented and resulted in TH1/TH2 balance. | (Heo et al., 2011) | ||||
Leaves | Methanolic extract | – | In vitro | Dose-dependent reduction of IL-4, IL-5, IL-13 and GM-CSF production in DP2-stimulated BEAS-2B cells at concentration range of 5-50 µg/ml with involvement of decreased phosphorylation of JNK and p38. | (Liu et al., 2013) | |
Leaves | Rosmarinic acid methyl ester (41) | Phenolic compound | In vitro | Possessed potent inhibitory activity on β-hexosaminidase from RBL-2H3 cells with IC50 of 9.9 ± 0.8 µg/ml. | (Zhu et al., 2014) | |
Leaves | 8-hydroxy-5,7-dimethoxyflavanone (4) | Flavanone | In vivo | Oral administration of (4) inhibited PCA reaction at dose of 5 mg and allergic nasal response at dose of 1.5 mg. | (Kamei et al., 2017) | |
In vitro | Significant suppressive effect on histamine release from RBL-2H3 cells was observed with IC50 of 68.5 µM. | (Kamei et al., 2017) | ||||
Leaves | Crude extract | – | In vivo | Decreased serum IgE level was observed in the blood of Der f-challenged mice. | (Komatsu et al., 2016) | |
In vitro | Reduced CD4+/CD8+ ratio in splenic T lymphocytes with percentage of 1.50 ± 0.07%. | (Komatsu et al., 2016) | ||||
Phlomis umbrosa Turcz. | Roots | Aqueous extract | – | In vivo | At dose of 1 g/kg, plasma histamine release only recorded with 0.023 ± 0.002 µg/ml in compound 48/80- sensitized mice. Anal, oral and intraperitoneal administration of 0.01–1 g/kg extract resulted in dose-dependent reduction in PCA reaction. | (Shin et al., 2008; Shin and Lee, 2003) |
In vitro | Significant inhibition of histamine release from RPMC activated by compound 48/80 or anti-DNP IgE recorded at doses of 0.1 mg/ml and 1 mg/ml. Extract attenuated the secretion of IL-1β, IL-6 and TNF-α in PMACI-stimulated HMC-1 cells. | (Shin et al., 2008; Shin and Lee, 2003) | ||||
Pogostemon cablin (Blanco) Benth | – | Aqueous extract | – | In vivo | Intraperitoneal administration of extract caused a dose-related suppression of systemic anaphylaxis induced by compound 48/80 in sensitized mice across doses of 10–1,000 mg/kg. At doses ranging from 1–1,000 mg/kg, PCA reaction induced by DNP-HSA was reduced in a concentration-dependent manner in sensitized rats. | (Yoon et al., 2016) |
In vitro | Suppressed the release of histamine and β-hexosaminidase from RPMC across concentrations of 1–1,000 µg/ml. Expression and secretion of TNF-α, IL-6 and IL-8 was inhibited in HMC-1 cells at doses of 1–100 µg/ml due to the attenuation of NF-κB activation. | (Yoon et al., 2016) | ||||
– | Patchouli oil | – | In vivo | Significant reduced PCA reaction in ovalbumin-challenged rats and suppressed delayed-type hypersensitivity at doses of 20, 40 and 80 mg/kg of Patchouli oil. | (He et al., 2013) | |
Ex vivo | Decreased contraction responses in guinea pig ileum at concentrations of 0.01, 0.02 and 0.04 mg/ml of Patchouli oil. | (He et al., 2013) | ||||
Prunella vulgaris var. lilacina Nakai | Whole plant | 2α,3α-dihydroxyurs-12-en-28-oic acid (42) | Triterpenoid | In vitro | Significant suppressive effect on β-hexosaminidase from RBL-2H3 with IC50 value of 57 µM. | (Ryu et al., 2000) |
Whole plant | Aqueous extract | – | In vivo | At doses of 0.5 and 1 g/kg, sensitized rats completely protected from anaphylatic death. Oral administration of extract with doses ranging from 0.001–1 g/kg dose-dependently reduced PCA reaction. | (Kim et al., 2007; Shin et al., 2001) | |
In vitro | Inhibition of intracellular calcium level caused downstream decreased release of histamine from RPMC in a concentration dependent manner with concentration range of 0.001–1 mg/ml. RPMC also showed with significant reduction of TNF-α production with the pretreatment of 0.01 mg/ml and 0.1 mg/ml. | (Kim et al., 2007; Shin et al., 2001) | ||||
Spike | β-amyrin (43), 2α,3α,23-trihydroxyursa-12,20(30)-dien-28-oic acid (44), Euscaphic acid (45) |
Triterpenoid | In vitro | Observed with inhibition of histamine release from HMC-1 cells with 46.7%, 57.9% and 54.2% respectively. | (Choia et al., 2016) | |
Rosmarinus officinalis Linn. | Leaves | Carnosic acid (5) | Polyphenol | In vivo | PCA reaction was significantly suppressed at 100 mg/kg in sensitized mice with percentage inhibition of 67.1%. | (Mizushina et al., 2014) |
In vitro | (5) inhibited β-hexosaminidase release from PMACI A23187-stimulated RBL-2H3 cells at 10 µM. | (Mizushina et al., 2014) | ||||
Salvia miltiorrhiza Bunge | Roots | 15,16-dihydrotanshinone-I (7), Cryptotanshinone (9) | Diterpene | In vitro | (7) and (9) significantly suppressed the release of β-hexosaminidase from RBL-2H3 cells with IC50 values of 16 ± 2.4 µM and 36 ± 3.7 µM respectively. | (Choi and Kim, 2004; Ryu et al., 1999) |
Leaves | Ethanolic extract | – | In vivo | Oral administration of 25–100 mg/kg extract dose-dependently inhibited PCA reaction in anti-DNP IgE-stimulated rats. | (Yang et al., 2008) | |
In vitro | Dose-related inhibition of COX-1 and COX-2-dependent prostaglandin D2 production observed with IC50 values of 3.96 and 21.54 µg/ml respectively in BMMC. Suppression of leukotriene C4 generation and β-hexosaminidase release was seen in BMMC with IC value of 2.6 and 22.4 µg/ml. | (Yang et al., 2008) | ||||
Rhizome | Tanshinone I (6), 15,16-dihydrotanshinone-I (7), Tanshinone IIA (8), Cryptotanshinone (9) |
Diterpene | In vivo | (6), (7), (8) and (9) significantly suppressed PCA reaction at dose of 50 mg/kg with percentage inhibition of 59%, 49%, 35% and 32% respectively in sensitized mice. | (Trinh et al., 2010a) | |
In vitro | Potent inhibition of IL-4 and TNF-α expression by (6), (7) and (8) at dose of 50 µM in RBL-2H3 cells. | (Trinh et al., 2010a) | ||||
Roots | 15,16-dihydrotanshinone-I (7) | Diterpene | In vitro | (7) at 20 µM produced 90% suppression on degranulation and generation of prostaglandin D2 and leukotriene C4 in IgE/Ag-stimulated BMMC through inhibition of FcɛRI-mediated Syk-dependent signal pathway. | (Li et al., 2015) | |
Salvia plebeia R. Brown | Whole plant | Aqueous extract | – | In vivo | No anaphylactic death occurred in compound 48/80-induced rats with intraperitoneal administration of 0.5 and 1 g/kg extract. At doses ranging from 0.01–1 g/kg, intraperitoneal and oral administration of extract showed with dose-dependent inhibition of PCA reaction. | (Shin and Kim, 2002) |
In vitro | Concentration-dependent reduction histamine release from RPMC activated by compound 48/80 or anti-DNP IgE at a concentration range of 0.001–1 mg/ml. TNF-α production from RPMC was significantly inhibited at concentrations of 0.01–1 mg/ml whereas cAMP level in RPMC significantly elevated compared with that of basal cells. | (Shin and Kim, 2002) | ||||
Whole plant | Ethanol extract | – | In vivo | Oral administration of 100 mg/kg extract significantly suppressed serum IgE level, serum histamine, eosinophil count, pro-inflammatory cytokines (IFN-γ and TNF-α) expression, TH1, TH2 and TH17 cytokines expression in Der f-sensitized mice. | (Choi et al., 2014) | |
Schizonepeta tenuifolia (Benth.) Briq. |
Whole plant | Aqueous extract | – | In vivo | 100% protection from systemic anaphylaxis was observed with doses of 0.5 and 1 g/kg in compound 48/80-challenged rats whereas a marked suppression in PCA reaction was seen in orally administered of 0.1 and 1 g/kg of anti-DNP IgE-sensitized rats. | (Shin et al., 1999) |
In vitro | Significant inhibition of compound 48/80 or IgE-mediated histamine release from RPMC was marked at concentration range of 0.01–1 mg/ml. A potent inhibition of TNF-α production observed at 1 mg/ml with a content of 0.889 ± 0.747 ng/ml. | (Shin et al., 1999) | ||||
Whole plant | Extract with phosphate buffered saline/olive oil (P/O) in proportion of (9:1) mixture | – | In vivo | Skin thickening and hyperplasia of epidermis and dermis in DNCB-sensitized mice remarkably decreased by 38.15% and 42.37% respectively with treatment of 1% of extract in P/O (9:1) mixture. | (Choi et al., 2013) | |
In vitro | DNCB-induced mice observed with reduced serum levels of IgE, TNF-α and IL-6, recorded with 46.26%, 41.97% and 70.42% inhibition respectively with the treatment of 1% of extract in P/O (9:1) mixture. |
(Choi et al., 2013) | ||||
– | Aqueous extract | – | In vitro | Pro-inflammatory cytokines (IL-6, IFN-γ and TNF-α) and pro-allergic TH2 cytokines (IL-4 and IL-13) in RBL-2H3 were decreased with the treatment of 100 µg/ml of aqueous extract. β-hexosaminidase release from RBL-2H3 cells reduced significantly at dose of 10 µg/ml. | (Lin et al., 2018) | |
Scutellaria baicalensis Georgi | Roots | Wogonin (10), Ganhuangenin (11), Wogonoside (12), 3,5,7, 2’,6’-pentahydroxyflavanone (13) |
Flavonoid | Ex vivo | (10), (11) and (12) significantly inhibited the production of IgE from concanavalin A-stimulated rat spleen lymphocytes at concentrations of 10.0 and 100.0 µM. Histamine and leukotriene B4 release from rat PEC was markedly suppressed at dose of 100 µM for all flavonoids. | (Lim, 2003; Lim et al., 2003) |
Roots | Aqueous extract | – | In vivo | Oral administration of 50 mg/kg extract selectively inhibited the release of IL-5 in mice. | (Kim et al., 2010) | |
Roots | Baicalin (46) | Flavone glycoside | In vitro | Histamine and leukotriene release from OVA-sensitized guinea pig lung mast cells were potently suppressed at doses of 10, 30 and 60 µg. The standardized extract of (46) exhibited a more potent outcome than pure (46) at 60 µg only. |
(Kim et al., 2010) | |
Whole plant | Ethanolic extract | – | In vivo | Exhibited 6.6% inhibition of PCA reaction in sensitized-rats at 280 mg/kg. | (Jung et al., 2012) | |
In vitro | 40% reduction of histamine content in compound 48/80-stimulated RPMC with dose of 10 µg/ml. Significant reduced production of TNF-α and IL-8 in PMACI-stimulated HMC-1 cells with inhibition of MAPK activation at concentration range of 1–100 µg/ml. | (Jung et al., 2012) | ||||
Roots | Aqueous extract | – | In vivo | Topical application of 5% extract reduced DNFB-induced cutaneous reaction by 31% as compared to control group. | (Kim et al., 2013) | |
In vitro | Significantly suppressed β-hexosaminidase release from RBL-2H3 at doses of 125, 250 and 500 ppm with percentage inhibition of 19%, 34% and 60% respectively. | (Kim et al., 2013) | ||||
Whole plant | Crude ethanol extract | – | In vivo | OVA-sensitized mice were protected from food allergy anaphylactic death by 60% and observed with significantly suppression of OVA-specific IgE, IL-17, TH2 cytokines (IL-4, IL-5, IL-10, IL-13) and TH1 cytokines (IFN-γ and IL-12) with the treatment of 25 mg/kg of extract. |
(Shin et al., 2014b) | |
– | Wogonin (10), Baicalin (46), Baicalein (47) |
Flavonoid | Ex vivo | (10) suppressed the production of TH2 cytokines (IL-4, IL-5, IL-10, IL-13) and IFN-γ without causing cytotoxicity in OVA-sensitized mice splenocytes at 50 µmol/ml as compared to (46) and (47). | (Shin et al., 2014a) | |
In vivo | Oral administration of 1 mg/kg of (15) potently decreased the production of OVA-specific IgE, IL-5, IL-10 and IL-13 in sensitized mice. | (Shin et al., 2014a) | ||||
Roots | Aqueous extract | – | In vivo | Attenuation of DNCB-induced epidermal thickness, leukocytes infiltration, serum IgE, IL-4, IFN-γ and TNF-α production in BALB/c mice skin. | (Kim et al., 2016) | |
Root | Ethanol extract, acetone extract and ethyl acetate extract | – | In vivo | The highest inhibitory activity against 4-AP-induced allergic skin pruritus, histamine-induced paw swelling, ear PCA reaction, anaphylaxis ear swelling and total serum IgE level was seen with 1.42 g/kg of ethanol extract in sensitized mice. | (Li et al., 2014) | |
Rhizome | Baicalin (46), Baicalein (47), Oroxylin A (14) |
Flavonoid | In vivo |
(46) which was orally administered metabolized into (47) and (14). Metabolite, (14) possessed a more potent anti-histamine activity, seen with significant reduced histamine-induced scratching behaviour and vascular permeability in sensitized mice at doses of 20 and 50 mg/kg. |
(Trinh et al., 2010b) | |
In vitro | Metabolite of (46), (14) remarkably inhibited the contraction of guinea pig ileum with IC50 value of 0.28 mmol/L. | (Trinh et al., 2010b) | ||||
– | Oroxylin A (14) | Flavonoid | In vivo | Significantly reduced eosinophils infiltration in BALF and airway hyperresponsiveness in OVA-sensitized mice. Potent attenuation of serum IgE level, TH2 cytokines (IL-4, IL-5 and IL-13) production and NF-κB activation with oral administration of 15, 30 and 60 mg/kg. | (Zhou et al., 2016) | |
Roots | Linoleic acid (50) | Fatty acid | Ex vivo | Significantly suppressed the production of IL-4, IL-5, IL-10 and IL-13 but enhanced secretion of IFN-γ and IL-12, resulted in TH1/TH2 balance at 50 µg/L. | (Jung et al., 2017) | |
– | Baicalein (47) | Flavonoid | In vivo | (47) induced CD4+ FOXP3 + T cell differentiation in ovalbumin-sensitized mice at concentrations of <10 µmol/L without causing cell death. | (Bae et al., 2016) | |
Stachys riederi var. japonica Miq. | Whole plant | Aqueous extract | – | In vivo | Dose-dependent inhibition was resulted in the occurrence of systemic anaphylaxis at concentration range of 0.005–1 g/kg and significant reduction of PCA reaction at concentrations of 0.1 and 1 g/kg. | (Shin, 2004) |
In vitro | At doses of 0.1 and 1 mg/ml, a significant decrease release of histamine from RPMC and diminished secretion of TNF-α and IL-6 from HMC-1 cells. | (Shin, 2004) | ||||
Teucrium japonicum Houttuyn |
Whole plant | Aqueous extract | – | In vivo | Serum histamine release was significantly reduced at 100 and 1,000 mg/kg, with 500 mg/kg as the effective dose that completely protected compound 48/80-induced mice from systemic anaphylaxis. At doses ranging from 1–1,000 mg/kg, a dose-dependent inhibition of PCA reaction was resulted in anti-DNP IgE-challenged mice. | (Kim et al., 2009) |
In vitro | Significant reduction of compound 48/80-induced intracellular calcium and downstream histamine release from RPMC was observed at 1 mg/ml. Gene expression of TNF-α was diminished dose-dependently at 0.01–1 mg/ml with the involvement of NF-κB in PMACI-stimulated HMC-1 cells. | (Kim et al., 2009) | ||||
Thymus vulgaris Linn. |
Leaves | 2-isopropyl-5-methylphenol (15) | Monoterpenoid phenolic | In vivo | Dose-dependently inhibited recruitment of inflammatory cells, reduced airway hyperreponsiveness, suppressed level of OVA-specific IgE, TH2 cytokines in BALF at concentrations of 4, 8 and 16 mg/kg. | (Zhou et al., 2014) |
Leaves | n-hexane extract | – | In vivo | Portrayed intermediate inhibitory activity on histamine release with 46.22 ± 0.08%. | (Ikawati et al., 2001) | |
– | 2-isopropyl-5-methylphenol (15), Carvacrol (51) | Monoterpenoid phenolic | In vivo | (15) and (51) reduced delayed-type hypersensitivity by 26% and 50% respectively in ovalbumin-sensitized mice. | (Gholijani and Amirghofran, 2016) | |
Ex vivo | Both compounds led to reduction of IL-2, IFN-γ, IL-4, IL-17 level and T-bet expression but increased level of IL-10 and TGF-β in mice splenocytes cultures. | (Gholijani and Amirghofran, 2016) | ||||
Vitex negundo Linn. |
Leaves | Aqueous subfraction of ethyl acetate fraction | – | In vitro | Mast cell stabilizing activity with 80.99 ± 0.7231% was observed in rat mesenteric mast cells at dose of 500 µg/ml. | (Patel and Deshpande, 2011) |
Leaves | 5-hydroxy-3, 6, 7, 3’,4’-pentamethoxyflavone (52) | Flavonoid | In vivo | 200 mg/kg extract demonstrated significant reduction of eosinophil count in BALF and serum bicarbonate level in egg albumin sensitized guinea pigs. | (Patel and Deshpande, 2013) | |
Vitex rotundifolia Linn. | Fruits | Aqueous extract | – | In vivo | Dose-dependent reduction of systemic anaphylaxis reaction in compound 48/80-induced rats across concentration range of 0.0001–1 g/kg. Significant suppression of PCA reaction marked at doses of 0.5 and 1 g/kg in sensitized rats. | (Shin et al., 2000) |
In vitro | Histamine release from RPMC was reduced in a dose-dependent manner at dose range of 0.001–1 mg/ml and marked inhibition of TNF-α production at 0.001 mg/ml. | (Shin et al., 2000) | ||||
Fruits | 1H,8H-pyrano[3,4-c]pyran-1,8-dione (16) | Pyran | In vivo | Serum IgE, eosinophil counts and IL-5 production in BALF were significantly suppressed by 43%, 82% and 34% respectively. IL-4 and IL-5 level significantly decreased in CD4+ T cells in TH2 skewed condition with treatment. | (Lee et al., 2009) | |
In vitro | Eosinophil migration and eotaxin production were reduced by 48% and 70% respectively at 10 µg/ml in A549 cell media. | (Lee et al., 2009) | ||||
Fruits | Casticin (53) | Flavonoid | In vitro | Up to 63% of eosinophil migration inhibition was observed in A549 cell media with pretreatment of 10 µg/ml. Eotaxin level was reduced from concentration range of 0.1–10 µg/ml in A549 cells. | (Koh et al., 2011) | |
– | Aqueous extract | – | In vivo | Oral administration of 100 mg/kg extract caused 86% inhibition of eosinophilia, reduction of TH2 cytokines (IL-4, IL-5, IL-13) and TNF-α level in BALF and decreased serum IgE level in ovalbumin-sensitized mice. | (Bae et al., 2013) | |
Vitex trifolia Linn. | Leaves | n-hexane and ethanolic extract | – | In vitro | Both n-hexane and ethanolic extract highly suppressed histamine release by 80.13 ± 3.95 and 81.58 ± 0.24% respectively in RBL-2H3 cells. | (Ikawati et al., 2001) |
Leaves | Viteosin-A (48), Vitexicarpin (49) |
Flavonoid | Ex vivo | (48) and (49) respectively reduced histamine-induced tracheal contraction by 27.1% and 66.2% at 0.00013 M and percentage increased to 47.9% and 97.2% respectively when raised to 0.0004 M. | (Alam et al., 2002) | |
Zataria multiflora Boiss. | Whole plant | Hydro-ethanolic extract | – | In vitro | Observed with increment of Treg cells, TH1/TH2 ratio, IFN-γ/IL-4 ratio, IFN-γ and FOXP3 expression. Significant reduction of TH2 and TH17 cells and decreased expression of IL-4, IL-17 and TGF-β occurred in sensitized mice spleen cells. | (Kianmehr et al., 2017) |
Seeds | Hydro-ethanolic extract | – | In vivo | Increased IFN-γ and decreased IL-4 were resulted in ovalbumin-sensitized guinea pigs with the oral administration of extract. | (Boskabady et al., 2013) | |
In vitro | Achieved TH1/TH2 balance with enhanced ratio of IFN-γ/IL-4 in PHA-stimulated hPBMC. | (Boskabady et al., 2013) |